Company / Interest Expense per Share
Pfizer Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.47
FY2025
5-year range
$0.23 / $0.54
FY2021-FY2025
Trend
-13.2%
vs FY2024
Sector context
#11 of 43
Health Care
What the data says
At $0.47, Pfizer's interest expense per share ranks #33 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2017 to $0.54 in FY2024.
Based on SEC 10-K filings.
0.47 in FY2025 with a 5-year CAGR of +14.1%. Top quartile in the Health Care sector.
Increased from $0.23 to $0.47 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +22.1%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
-97.5% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 13.2% year-over-year.
- Ranks #11 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2024.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | -13.2% |
| FY2024 | $0.54 | +138.4% |
| FY2023 | $0.23 | -12.1% |
| FY2022 | $0.26 | -7.2% |
| FY2021 | $0.28 | +14.3% |
| FY2020 | $0.24 | -6.6% |
| FY2019 | $0.26 | +34.8% |
| FY2018 | $0.19 | +0.5% |
| FY2017 | $0.19 | -9.5% |
| FY2016 | $0.21 | +21.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026